These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1322185)

  • 21. Absence of cytomegalovirus and Epstein-Barr virus expression in labial salivary glands of patients with chronic graft-versus-host disease.
    Mariette X; Cazals-Hatem D; Agbalika F; Selimi F; Brunet M; Morinet F; Gluckman E
    Bone Marrow Transplant; 1996 Apr; 17(4):607-10. PubMed ID: 8722363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of skin biopsies in the diagnosis and management of graft-vs-host disease in early postallogeneic bone marrow transplantation.
    Zhou Y; Barnett MJ; Rivers JK
    Arch Dermatol; 2000 Jun; 136(6):717-21. PubMed ID: 10871932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abortive human cytomegalovirus infection in patients after allogeneic bone marrow transplantation.
    de Gast GC; Boland GJ; Vlieger AM; de Weger RA; Verdonck LF; Zwaan FE; Jiwa NM
    Bone Marrow Transplant; 1992 Apr; 9(4):221-5. PubMed ID: 1318140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transition of T cell receptor gamma/delta expressing double negative (CD4-/CD8-) lymphocytes after allogeneic bone marrow transplantation.
    Yabe M; Yabe H; Hattori K; Hinohara T; Morimoto T; Kato S; Kusunoki A
    Bone Marrow Transplant; 1994 Nov; 14(5):741-6. PubMed ID: 7889006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between donor cytomegalovirus immunity and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Jacobsen N; Andersen HK; Skinhøj P; Ryder LP; Platz P; Jerne D; Faber V
    Scand J Haematol; 1986 May; 36(5):499-506. PubMed ID: 3016881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and monitoring of human cytomegalovirus infection in bone marrow transplant recipients by quantitative competitive PCR.
    Ziyaeyan M; Sabahi F; Alborzi A; Mahboudi F; Kazemnejad A; Ramzi M; Moravej A; Jaberi MM
    Exp Clin Transplant; 2006 Jun; 4(1):470-4. PubMed ID: 16827646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The biology of human cytomegalovirus infection after bone marrow transplantation.
    Zaia JA
    Int J Cell Cloning; 1986; 4 Suppl 1():135-54. PubMed ID: 3018099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of CMV/human herpes virus-6 positivity in bronchoalveolar lavage fluids as early detection of acute GVHD following BMT: evidence of a significant relationship.
    Takemoto Y; Takatsuka H; Wada H; Mori A; Saheki K; Okada M; Tamura S; Fujimori Y; Okamoto T; Kakishita E; Kanamaru A
    Bone Marrow Transplant; 2000 Jul; 26(1):77-81. PubMed ID: 10918408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid detection of human cytomegalovirus DNA in peripheral blood leukocytes of viremic transplant recipients by the polymerase chain reaction.
    Jiwa NM; Van Gemert GW; Raap AK; Van de Rijke FM; Mulder A; Lens PF; Salimans MM; Zwaan FE; Van Dorp W; Van der Ploeg M
    Transplantation; 1989 Jul; 48(1):72-6. PubMed ID: 2546301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human herpesvirus 6 is an important pathogen in infectious lung disease after allogeneic bone marrow transplantation.
    Buchbinder S; Elmaagacli AH; Schaefer UW; Roggendorf M
    Bone Marrow Transplant; 2000 Sep; 26(6):639-44. PubMed ID: 11035370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne Bone Marrow Transport Group.
    Appleton AL; Sviland L; Peiris JS; Taylor CE; Wilkes J; Green MA; Pearson AD; Kelly PJ; Malcolm AJ; Proctor SJ
    Bone Marrow Transplant; 1995 Dec; 16(6):777-82. PubMed ID: 8750269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epithelial class II antigen expression in cutaneous graft-versus-host disease.
    Beschorner WE; Farmer ER; Saral R; Stirling WL; Santos GW
    Transplantation; 1987 Aug; 44(2):237-43. PubMed ID: 3307048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marked increase of CD57+CD16- cells in long-term survivors of graft-versus-host disease after allogeneic bone marrow transplantation.
    Fukuda H; Nakamura H; Tominaga N; Teshima H; Hiraoka A; Shibata H; Masaoka T
    Jpn J Clin Oncol; 1992 Aug; 22(4):238-43. PubMed ID: 1359173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring transplant patients for human cytomegalovirus: Diagnostic update.
    Gerna G; Lilleri D
    Herpes; 2006 May; 13(1):4-11. PubMed ID: 16732996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies.
    Ringdén O; Remberger M; Carlens S; Hagglund H; Mattsson J; Aschan J; Lönnqvist B; Klaesson S; Winiarski J; Dalianis T; Olerup O; Sparrelid E; Elmhorn-Rosenborg A; Svahn BM; Ljungman P
    Transplantation; 1998 Sep; 66(5):620-5. PubMed ID: 9753343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and practical value of human cytomegalovirus DNAemia detection by semi-nested PCR for follow-up of BMT recipients.
    Imbert-Marcille BM; Milpied N; Coste-Burel M; Richet B; Moreau P; Harousseau JL; Billaudel S
    Bone Marrow Transplant; 1995 Apr; 15(4):611-7. PubMed ID: 7655389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection.
    Gabanti E; Lilleri D; Ripamonti F; Bruno F; Zelini P; Furione M; Colombo AA; Alessandrino EP; Gerna G
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2192-2202. PubMed ID: 26260678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Qualitative detection of human cytomegalovirus DNA in the plasma of bone marrow transplant recipients: value as a predictor of disease progression.
    Behzad-Behbahani A; Ehsanipour F; Alborzi A; Nourani H; Ramzi M; Rasoli M
    Exp Clin Transplant; 2004 Jun; 2(1):196-200. PubMed ID: 15859928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical changes in sigmoid colon after allogeneic and autologous bone marrow transplantation.
    Forbes GM; Erber WN; Herrmann RP; Davies JM; Collins BJ
    J Clin Pathol; 1995 Apr; 48(4):308-13. PubMed ID: 7615847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.